Login / Signup

Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial.

Shuya LiHong-Qiu GuHongguo DaiGuozhi LuYong-Jun Wang
Published in: Stroke and vascular neurology (2024)
NCT05295173.
Keyphrases